Variability between batches of reagents and calibrators and its consequences for measurement verification
Authors:
B. Friedecký
Authors place of work:
ÚKBD Fakultní nemocnice, Hradec Králové
Published in the journal:
Klin. Biochem. Metab., 24, 2016, No. 4, p. 170-172
Summary
We deals with recently published data on the lot-to-lot variation in laboratory measurements by some important analytes. This variability can reach in some cases more than 10 %. We discuss possible significant impacts for diagnostic processes and also for external quality assessment. Lot-to-lot variability in the diagnostic strips of glucose POCT and self-monitoring measurement systems are applied as integral part of ISO 15197 standard. We introduce ways and possibilities for establishment and assessment of these variations. Quantification and documentation of lot-to-lot variation is necessary tool for verification of measurement methods in clinical laboratories.
Keywords:
lot, reagents, calibrators, variation, verification.
Zdroje
1. ISO 15197:2013. In vitro diagnostic test systems:requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva. 2013.
2. Baumstark, A., Pleus, S., Schmid, C., Link, M., Haug, C. Lot-to-lot variability of test strips and accuracy assessment of systems for self-monitoring for blood glucose according to ISO 15197. J Diabet. Sci. Technol.,
2012, 6/5, p. 1076-1086.
3. Brazg, R. L., Kleff, L. D., Partin, C. C. Performance variability of seven commonly used for self-monitoring of a blood glucose systems:clinical considerations for patients and providers. J. Diabet. Sci. Technol., 2013, 7, p. 144-152
4. Muller, P., Hattener, A., Stephan, P. Assessing system accuracy of blood glucose monitoring systems using rectengle target plot. J. Diabet. Sci. Technol., 2015 pii:19322968815612496.
5. Baumstark, A., Pleus, S., Schmid, C., Link, M., Haug, C., Freckmann, G. Lot-to lot variability of test strips and accuracy assessment of systems for self-monotoring of blood glucose. J. Diabet. Sci. Technol., 2012, 6, p. 1076-1086.
6. Hofmans, M., Oyaert, M., De Schriver, P., Nobels, F., Van Hoovels, L. Clinical laboratories havea critical role in test strips lot management in glucose point-ofcare testing. Clin. Chem. Lab. Med., 2016, 54 (5), e155- 159
7. http://www.skup.nu
8. Miller G. W. Time to Pay Attention to Reagent and Calibrator Lots for Proficiancy Testing. Clin. Chem., 2016, doi:10. 1373/clinchem. 2016. 255802
9. Bais, R. What Information Should manufacturers Provide on Their Procedures? Clin. Chem., 2006, 52, p. 1624-1625.
10. http://www.nist.gov/director/prog-ofc/report04-1.pdf
11. Van Houcke, S. K., Stepman, H. C. M., Thienpont, L. M., Fiers, T., Stove, V. et al. Long-term stability of laboratory tests and practical implications for quality management. Clin. Chem. Lab. Med., 2013, 51, p. 1227-1231
12. De Grande, L. A. C., Goosens, K., Van Uytfanghe, K., Stockl, D., Thienpont, L. M. The Empower projecta new way of assessing and monitoring test comparability and stability. Clin. Chem. Lab. Med., 2015, 53:1197- 1204
13. Thaler, M. A., Jakoubov, R., Bietenbeck, A., Luppa, P. B. Clinically relevant lot-to-lot reagent difference in a commercial immunoturbidimetric assay for glycated hemoglobin A1c. Clin. Biochem., 2015, 48, p. 1167- 1170
14. Hayden, J. A., Schmeling, M., Hoofnagle, A. N. Lotto-lot variations in a quantitative Lateral-Flow Immunoassay for chronic pain drug momitoring. Clin. Chem., 2014, 60, p. 896-897
15. Vos, J. B., Visser, P. J., Verhey, F., Aalten, P., Knol, D. et al. Variability of CSF Alzheimers disease biomarkers: Implications for Clinical Practice. Plos One, 2014, 9:e100784
16. Stavelin, A., Riksheim, B. O., Christiansen, N. G., Sandberg, S. The importance of reagent lot registration in external quality assurance/proficiency testing schemes. Clin. Chem., 2016. DOI:10. 1073/clinchem. 205. 247585
17. Topic, E., Nikolac, N., Panteghini, M., Theodorsson, E., Salvagnano, G. L., Miller, M. et al. How to assess the quality of your analytical methods? Clin. Chem. Lab. Med., 2015, DOI:10. 1515/cclm-2015-0869
18. Braga, F., Panteghini, M. Verification of in vitro medical diagnostics (IVD)metrological traceability. Responsibilities and strategies. Clin. Chim. Acta, 2013, http://dx. doi.org/10.1016/jcca. 2013.11.022
19. Bais, R., Chester, D. More on Lot-to-Lot Changes. Clin. Chem., 2014, 60, p. 413-414.
20. Algeciras-Schimmich, A., Bruns, D. E., Boyd, J. C., Bryant, S. C., LaFortune, K. A., Grebe, S. K. Failure of current laboratory protocols to detect lot-to-lot reagent differences: finding and possible solutions. Clin. Chem., 2013, 59, p. 1187-1194
21. Cho, M. C., Kim, S. Y., Jeong, T. D., Lee, W., Chua, S., Min, W. K. Statistical validation of reagent lot changes in the clinical chemistry laboratory con confer insights on good clinical laboratory. Ann. Clin. Biochem., 2014, 51, p. 688-694.
22. Friedecký, B., Šprongl, L., Kratochvíla, J., Plzák, Z. Doporučení k provedení validace a verifikace analytických metod v klinických laboratořích. Klin. Biochem. Metab., 2011, 1, p. 36-44.
Štítky
Clinical biochemistry Nuclear medicine Nutritive therapistČlánok vyšiel v časopise
Clinical Biochemistry and Metabolism
2016 Číslo 4
Najčítanejšie v tomto čísle
- The precision and bias of measurement methods according to EP15 A3
- Metabolism of bilirubin and its biological properties
- New trends in immunochemistry
- A comparison between ALP catalytic concentrations determined by the routine ALP measurement (Roche Diagnostics) and those obtained by the alkaline phosphatase approach (BLW Diagnostics